The Market Reports

Index

1 Anti-Tumor Drugs Market Overview
1.1 Product Overview and Scope of Anti-Tumor Drugs
1.2 Anti-Tumor Drugs Segment by Type
1.2.1 Global Anti-Tumor Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Surgical
1.2.3 Chemotherapy
1.2.4 Radiation
1.2.5 Targeted
1.2.6 Immunotherapy
1.3 Anti-Tumor Drugs Segment by Application
1.3.1 Global Anti-Tumor Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Global Anti-Tumor Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti-Tumor Drugs Revenue 2016-2027
1.4.2 Global Anti-Tumor Drugs Sales 2016-2027
1.4.3 Anti-Tumor Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Anti-Tumor Drugs Market Competition by Manufacturers
2.1 Global Anti-Tumor Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-Tumor Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-Tumor Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-Tumor Drugs Manufacturing Sites, Area Served, Product Type
2.5 Anti-Tumor Drugs Market Competitive Situation and Trends
2.5.1 Anti-Tumor Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-Tumor Drugs Players Market Share by Revenue
2.5.3 Global Anti-Tumor Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Anti-Tumor Drugs Retrospective Market Scenario by Region
3.1 Global Anti-Tumor Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Anti-Tumor Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Anti-Tumor Drugs Market Facts & Figures by Country
3.3.1 North America Anti-Tumor Drugs Sales by Country
3.3.2 North America Anti-Tumor Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Tumor Drugs Market Facts & Figures by Country
3.4.1 Europe Anti-Tumor Drugs Sales by Country
3.4.2 Europe Anti-Tumor Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Tumor Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Tumor Drugs Sales by Region
3.5.2 Asia Pacific Anti-Tumor Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Tumor Drugs Market Facts & Figures by Country
3.6.1 Latin America Anti-Tumor Drugs Sales by Country
3.6.2 Latin America Anti-Tumor Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-Tumor Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Tumor Drugs Sales by Country
3.7.2 Middle East and Africa Anti-Tumor Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-Tumor Drugs Historic Market Analysis by Type
4.1 Global Anti-Tumor Drugs Sales Market Share by Type (2016-2021)
4.2 Global Anti-Tumor Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Anti-Tumor Drugs Price by Type (2016-2021)

5 Global Anti-Tumor Drugs Historic Market Analysis by Application
5.1 Global Anti-Tumor Drugs Sales Market Share by Application (2016-2021)
5.2 Global Anti-Tumor Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Anti-Tumor Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Anti-Tumor Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Anti-Tumor Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Anti-Tumor Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis Anti-Tumor Drugs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Celgene
6.3.1 Celgene Corporation Information
6.3.2 Celgene Description and Business Overview
6.3.3 Celgene Anti-Tumor Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Celgene Anti-Tumor Drugs Product Portfolio
6.3.5 Celgene Recent Developments/Updates

7 Anti-Tumor Drugs Manufacturing Cost Analysis
7.1 Anti-Tumor Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Tumor Drugs
7.4 Anti-Tumor Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Tumor Drugs Distributors List
8.3 Anti-Tumor Drugs Customers

9 Anti-Tumor Drugs Market Dynamics
9.1 Anti-Tumor Drugs Industry Trends
9.2 Anti-Tumor Drugs Growth Drivers
9.3 Anti-Tumor Drugs Market Challenges
9.4 Anti-Tumor Drugs Market Restraints

10 Global Market Forecast
10.1 Anti-Tumor Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Tumor Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-Tumor Drugs by Type (2022-2027)
10.2 Anti-Tumor Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Tumor Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-Tumor Drugs by Application (2022-2027)
10.3 Anti-Tumor Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Tumor Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-Tumor Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Anti-Tumor Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-Tumor Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Anti-Tumor Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-Tumor Drugs Covered in This Study
Table 5. Global Anti-Tumor Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Anti-Tumor Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Anti-Tumor Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-Tumor Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-Tumor Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-Tumor Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-Tumor Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Tumor Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Tumor Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-Tumor Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global Anti-Tumor Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Anti-Tumor Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-Tumor Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America Anti-Tumor Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Anti-Tumor Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-Tumor Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-Tumor Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe Anti-Tumor Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-Tumor Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-Tumor Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-Tumor Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Anti-Tumor Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-Tumor Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-Tumor Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-Tumor Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Anti-Tumor Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-Tumor Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-Tumor Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-Tumor Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Anti-Tumor Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-Tumor Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-Tumor Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-Tumor Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global Anti-Tumor Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Anti-Tumor Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-Tumor Drugs Revenue Share by Type (2016-2021)
Table 42. Global Anti-Tumor Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global Anti-Tumor Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global Anti-Tumor Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Anti-Tumor Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-Tumor Drugs Revenue Share by Application (2016-2021)
Table 47. Global Anti-Tumor Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Anti-Tumor Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Roche Anti-Tumor Drugs Product
Table 52. Roche Recent Developments/Updates
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis Anti-Tumor Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Novartis Anti-Tumor Drugs Product
Table 57. Novartis Recent Developments/Updates
Table 58. Celgene Corporation Information
Table 59. Celgene Description and Business Overview
Table 60. Celgene Anti-Tumor Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Celgene Anti-Tumor Drugs Product
Table 62. Celgene Recent Developments/Updates
Table 63. Production Base and Market Concentration Rate of Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Anti-Tumor Drugs Distributors List
Table 66. Anti-Tumor Drugs Customers List
Table 67. Anti-Tumor Drugs Market Trends
Table 68. Anti-Tumor Drugs Growth Drivers
Table 69. Anti-Tumor Drugs Market Challenges
Table 70. Anti-Tumor Drugs Market Restraints
Table 71. Global Anti-Tumor Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 72. Global Anti-Tumor Drugs Sales Market Share Forecast by Type (2022-2027)
Table 73. Global Anti-Tumor Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 74. Global Anti-Tumor Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 75. Global Anti-Tumor Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 76. Global Anti-Tumor Drugs Sales Market Share Forecast by Application (2022-2027)
Table 77. Global Anti-Tumor Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 78. Global Anti-Tumor Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 79. Global Anti-Tumor Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 80. Global Anti-Tumor Drugs Sales Market Share Forecast by Region (2022-2027)
Table 81. Global Anti-Tumor Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 82. Global Anti-Tumor Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Tumor Drugs
Figure 2. Global Anti-Tumor Drugs Market Share by Type in 2020 & 2027
Figure 3. Surgical Product Picture
Figure 4. Chemotherapy Product Picture
Figure 5. Radiation Product Picture
Figure 6. Targeted Product Picture
Figure 7. Immunotherapy Product Picture
Figure 8. Global Anti-Tumor Drugs Market Share by Application in 2020 & 2027
Figure 9. Hospital Use
Figure 10. Clinic Use
Figure 11. Household
Figure 12. Other
Figure 13. Global Anti-Tumor Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Anti-Tumor Drugs Market Size 2016-2027 (US$ Million)
Figure 15. Global Anti-Tumor Drugs Sales 2016-2027 (K Units)
Figure 16. Global Anti-Tumor Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Anti-Tumor Drugs Sales Share by Manufacturers in 2020
Figure 18. Global Anti-Tumor Drugs Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Anti-Tumor Drugs Players: Market Share by Revenue in 2020
Figure 20. Anti-Tumor Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Anti-Tumor Drugs Sales Market Share by Region (2016-2021)
Figure 22. Global Anti-Tumor Drugs Sales Market Share by Region in 2020
Figure 23. Global Anti-Tumor Drugs Revenue Market Share by Region (2016-2021)
Figure 24. Global Anti-Tumor Drugs Revenue Market Share by Region in 2020
Figure 25. U.S. Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. U.A.E Anti-Tumor Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Anti-Tumor Drugs by Type (2016-2021)
Figure 50. Sales Market Share of Anti-Tumor Drugs by Application (2016-2021)
Figure 51. Sales Market Share of Anti-Tumor Drugs by Application in 2020
Figure 52. Revenue Share of Anti-Tumor Drugs by Application (2016-2021)
Figure 53. Revenue Share of Anti-Tumor Drugs by Application in 2020
Figure 54. Manufacturing Cost Structure of Anti-Tumor Drugs
Figure 55. Manufacturing Process Analysis of Anti-Tumor Drugs
Figure 56. Anti-Tumor Drugs Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed